Oct 2025 $3 M No. 5 $2 to $10 million 6
ABK Biomedical Inc: Raise no. 5, Oct 2025 × Investors in this round 6 investors had bought by the notice of Nov 3, 2025: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nova Scotia, Canada People named in the notice Anthony Headley · Executive Officer Aravind Arepally · Executive Officer David Dobrowsky · Executive Officer Gary Donofrio · Executive Officer Lucy Bellardine Bataneant · Executive Officer Marc Gregoire · Executive Officer Michael Mangano · Executive Officer, Director Mike Tyson · Executive Officer Aaron Berez · Director Carissa Bellardine Black · Director James Bellardine Eadie · Director James Bellardine McLaren · Director Joseph Bellardine Siletto · Director Keten Patel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”Signed by Michael Mangano, President and CEO. Source: SEC Form D, newest notice filed Nov 3, 2025. Read the notice at the SEC .
equity SEC Apr 2025 $26 M No. 4 $10 to $50 million 24
ABK Biomedical Inc: Raise no. 4, Apr 2025 × Investors in this round 24 investors had bought by the notice of May 13, 2025: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $26 M of $26 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nova Scotia, Canada People named in the notice Anthony Headley · Executive Officer Aravind Arepally · Executive Officer David Dobrowsky · Executive Officer Gary Donofrio · Executive Officer Lucy Bellardine Bataneant · Executive Officer Marc Gregoire · Executive Officer Michael Mangano · Executive Officer, Director Mike Tyson · Executive Officer Aaron Berez · Director Carissa Bellardine Black · Director James Bellardine Eadie · Director James Bellardine McLaren · Director Joseph Bellardine Siletto · Director Keten Patel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”Signed by Michael Mangano, President and CEO. Source: SEC Form D, newest notice filed May 13, 2025. Read the notice at the SEC .
equity SEC Dec 2022 $29 M No. 3 $10 to $50 million 23
ABK Biomedical Inc: Raise no. 3, Dec 2022 × Investors in this round 23 investors had bought by the notice of Dec 22, 2022: 23 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $29 M of $29 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nova Scotia, Canada People named in the notice Anthony Headley · Executive Officer Aravind Arepally · Executive Officer David Dobrowski · Executive Officer Gary Donofrio · Executive Officer Marc Gregoire · Executive Officer Michael Mangano · Executive Officer, Director Mike Tyson · Executive Officer Aaron Berez · Director Carissa Black · Director James McLaren · Director Ketan Patel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”Signed by Michael Mangano, President and CEO. Source: SEC Form D, newest notice filed Dec 22, 2022. Read the notice at the SEC .
equity SEC Sep 2022 $18 M No. 2 $10 to $50 million 16
ABK Biomedical Inc: Raise no. 2, Sep 2022 × Investors in this round 16 investors had bought by the notice of Sep 23, 2022: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $18 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nova Scotia, Canada People named in the notice Anthony Headley · Executive Officer Aravind Arepally · Executive Officer David Dobrowsky · Executive Officer Gary Donofrio · Executive Officer Marc Gregoire · Executive Officer Michael Mangano · Executive Officer, Director Mike Tyson · Executive Officer Aaron Berez · Director James McLaren · Director Ketan Patel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”Signed by Michael Mangano, President and CEO. Source: SEC Form D, newest notice filed Sep 23, 2022. Read the notice at the SEC .
equity SEC Apr 2019 $24 M No. 1 $10 to $50 million 10
ABK Biomedical Inc: Raise no. 1, Apr 2019 × Investors in this round 10 investors had bought by the notice of Apr 22, 2019: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $24 M of $24 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nova Scotia, Canada People named in the notice Bob Abraham · Executive Officer, Director David Dobrowski · Executive Officer Gary Donofrio · Executive Officer Marc Gregoire · Executive Officer Michael Mangano · Executive Officer, Director Michael Tyson · Executive Officer Aaron Berez · Director James McLaren · Director Robert Orr · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Michael Mangano, Chief Executive Officer and President. Source: SEC Form D, newest notice filed Apr 22, 2019. Read the notice at the SEC .
equity SEC